Literature DB >> 21315270

Unexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal.

Guozheng Liu1, Shuping Dou, Yuxia Liu, Minmin Liang, Ling Chen, Dengfeng Cheng, Dale Greiner, Mary Rusckowski, Donald J Hnatowich.   

Abstract

In connection with pretargeting, an amine-derivatized morpholino phosphorodiamidate oligomer (NH(2)-cMORF) was conjugated conventionally with p-isothiocyanate benzyl-DTPA (p-SCN-Bn-DTPA). However, after (111)In radiolabeling, unexpected label instability was observed. To understand this instability, the NH(2)-cMORF and, as control, the native cMORF without the amine were conjugated in the conventional manner. Surprisingly, the (111)In labeling of the native cMORF conjugate was equally effective as that of the NH(2)-cMORF conjugate (>95%) despite the absence of the amine group. Furthermore, heating the radiolabeled NH(2)-cMORF and native cMORF conjugates resulted in a 35% loss and a complete loss of the label, respectively. Since the (111)In labeled DTPA is known to be stable, the instability in both cases must be due to some unstable association of DTPA to the cMORF, presumably unstable association to some endogenous sites in cMORF. Based on this assumption, a postconjugation-prepurification heating step was introduced, and labeling efficiency and stability were again investigated. By introducing the heating step, the side products were dissociated, and after purification and labeling, the NH(2)-cMORF conjugate provided a stable label and high labeling efficiency with no need for postlabeling purification. The biodistribution of this radiolabeled conjugate in normal mice showed significantly lower backgrounds compared with the labeled unstable native cMORF conjugate. In conclusion, the conventional conjugation procedure to attach the p-SCN-Bn-DTPA to NH(2)-cMORF resulted in side product(s) that were responsible for the (111)In label instability. Adding a postconjugation-prepurification heating step dissociated the side products, improved the label stability and lowered tissue backgrounds in mice.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21315270      PMCID: PMC3052951          DOI: 10.1016/j.nucmedbio.2010.08.008

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  31 in total

Review 1.  Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Bioconjug Chem       Date:  2001 Jan-Feb       Impact factor: 4.774

Review 2.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

3.  Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.

Authors:  Guozheng Liu; Shuping Dou; Jiang He; Dongguang Yin; Suresh Gupta; Surong Zhang; Yi Wang; Mary Rusckowski; Donald J Hnatowich
Journal:  Appl Radiat Isot       Date:  2006-05-30       Impact factor: 1.513

4.  Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.

Authors:  Guozheng Liu; Kennedy Mang'era; Ning Liu; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Journal:  J Nucl Med       Date:  2002-03       Impact factor: 10.057

5.  Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules.

Authors:  Femke M van de Water; Otto C Boerman; Alfons C Wouterse; Janny G P Peters; Frans G M Russel; Rosalinde Masereeuw
Journal:  Drug Metab Dispos       Date:  2006-05-19       Impact factor: 3.922

6.  Solution-Phase Synthesis of a Combinatorial Thiohydantoin Library(1).

Authors:  Mui Mui Sim; Arasu Ganesan
Journal:  J Org Chem       Date:  1997-05-16       Impact factor: 4.354

7.  Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.

Authors:  Gabor Lendvai; Irina Velikyan; Mats Bergström; Sergio Estrada; Daniel Laryea; Maria Välilä; Satu Salomäki; Bengt Långström; Anne Roivainen
Journal:  Eur J Pharm Sci       Date:  2005-09       Impact factor: 4.384

8.  Improving the labeling of S-acetyl NHS-MAG(3)-conjugated morpholino oligomers.

Authors:  Guozheng Liu; Surong Zhang; Jiang He; Zhihong Zhu; Mary Rusckowski; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2002 Jul-Aug       Impact factor: 4.774

9.  Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.

Authors:  Guozheng Liu; Jiang He; Shuping Dou; Suresh Gupta; Jean-Luc Vanderheyden; Mary Rusckowski; Donald J Hnatowich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-23       Impact factor: 9.236

10.  Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.

Authors:  Fabio Gallazzi; Yi Wang; Fang Jia; Nalini Shenoy; Linda A Landon; Mark Hannink; Susan Z Lever; Michael R Lewis
Journal:  Bioconjug Chem       Date:  2003 Nov-Dec       Impact factor: 4.774

View more
  2 in total

1.  90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.

Authors:  Guozheng Liu; Shuping Dou; Yuxia Liu; Yuzhen Wang; Mary Rusckowski; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2011-11-03       Impact factor: 4.774

2.  A feasible approach to evaluate the relative reactivity of NHS-ester activated group with primary amine-derivatized DNA analogue and non-derivatized impurity.

Authors:  Shuping Dou; John Virostko; Dale L Greiner; Alvin C Powers; Guozheng Liu
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2015       Impact factor: 1.381

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.